赢得医疗技术市场.pdfVIP

Winning in China’s Changing Medtech Market The Boston Consulting Group (BCG) is a global management consulting firm and the world’s leading advisor on business strategy. We partner with clients from the private, public, and not-for- profit sectors in all regions to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. sight Our customized approach combines deep in into the dynamics of companies and markets with close collaboration at all levels of the client organization. This ensures that our clients achieve sustainable compet itive advantage, build more capable organizations, and secure lasting results. Founded in 1963, BCG is a private company with 81 offices in 45 countries. For more information, please visit . Winning in China’s Changing Medtech Market Ying Luo, John Wong, and Magen Xia July 2014 AT A GLANCE China’s medtech market is expected to grow rapidly in the years ahead, becoming the second largest global market for these products by 2020. China should there- fore be a strategic focus for medtech players over the next decade. An Evolving Landscape As the Chinese government continues to push health care reform, the midmarket in medtech will grow rapidly, with both fast-rising local companies and multi- nationals vying for penetration and dominance. This will prompt changes in how manufacturers manage sales and marketing, in some cases including their use of distributors. Strategies For Winning Multinationals